Trial · NCT02155803
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
NCT02155803, Phase 2, Phase 3, Unknown, Albany Medical College
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study. Trials, record NCT02155803. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02155803
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
- NCT number
- NCT02155803
- Status
- Unknown
- Phases
- Phase 2, Phase 3
- Enrollment
- 10 participants, estimated
- Lead sponsor
- Albany Medical College
- Conditions
- Sarcoidosis, Hypercalcemia Due to Sarcoidosis
- Interventions
- ACTHAR Gel (adrenocorticotropic hormone)
- First posted
- 2014-06-04
- Last updated
- 2015-01-26
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Reduction of 24 hour urine calcium | Between week 0 and week 12. | Reduction of 24 hour urine calcium in patients with sarcoidosis associated hypercalciuria (primary endpoint) between week 0 and week 12. |
| Secondary | Change in serum calcium during 12 week ACTHAR GEL treatment | Baseline compared to 12 weeks. | |
| Secondary | Change in 1,25 di-hydroxy Vitamin D during 12 week ACTHAR GEL treatment | Baseline compared to 12 weeks. | |
| Secondary | Change in patient global VAS during 12 week ACTHAR GEL treatment | Baseline to 12 weeks | |
| Secondary | Change in physician global VAS during 12 week ACTHAR GEL treatment | Baseline to 12 Weeks | |
| Secondary | Change in urinary symptoms during 12 week ACTHAR GEL treatment | Baseline to 12 Weeks | |
| Secondary | Change in Short Form-36 during 12 week ACTHAR GEL treatment | Baseline to 12 Weeks | |
| Secondary | Change in Sarcoidosis Health Questionnaire during 12 week ACTHAR GEL treatment | Baseline to 12 Weeks | |
| Secondary | Change in eCOST during 12 week ACTHAR gel treatment | Baseline to 12 Weeks | |
| Secondary | Change in adjusted eCOST (eCOSTadj) calculated as the eCOST/# organs with an eCOST score > 022 during 12 week ACTHAR gel treatment | Baseline to 12 Weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02155803
GET https://conductscience.org/api/trials/v1/NCT02155803/registered